Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion

The present global pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has lingered for over a year in its devastating effects. Diagnosis of coronavirus disease 2019 (COVID-19) is currently established with a polymerase chain reaction (PCR) test by means of oropha...

Full description

Bibliographic Details
Main Authors: Azuka Patrick Okwuraiwe, Chika Kingsley Onwuamah, Joseph Ojonugwa Shaibu, Samuel Olufemi Amoo, Fehintola Anthonia Ige, Ayorinde Babatunde James, Leona Chika Okoli, Abul-Rahman Ahmed, Jamda Ponmak, Judith O. Sokei, Sulaimon Akanmu, Babatunde Lawal Salako, Rosemary Ajuma Audu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191972/?tool=EBI
_version_ 1798035138169274368
author Azuka Patrick Okwuraiwe
Chika Kingsley Onwuamah
Joseph Ojonugwa Shaibu
Samuel Olufemi Amoo
Fehintola Anthonia Ige
Ayorinde Babatunde James
Leona Chika Okoli
Abul-Rahman Ahmed
Jamda Ponmak
Judith O. Sokei
Sulaimon Akanmu
Babatunde Lawal Salako
Rosemary Ajuma Audu
author_facet Azuka Patrick Okwuraiwe
Chika Kingsley Onwuamah
Joseph Ojonugwa Shaibu
Samuel Olufemi Amoo
Fehintola Anthonia Ige
Ayorinde Babatunde James
Leona Chika Okoli
Abul-Rahman Ahmed
Jamda Ponmak
Judith O. Sokei
Sulaimon Akanmu
Babatunde Lawal Salako
Rosemary Ajuma Audu
author_sort Azuka Patrick Okwuraiwe
collection DOAJ
description The present global pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has lingered for over a year in its devastating effects. Diagnosis of coronavirus disease 2019 (COVID-19) is currently established with a polymerase chain reaction (PCR) test by means of oropharyngeal-, nasopharyngeal-, anal-swabs, sputum and blood plasma. However, oral and nasal swabs are more commonly used. This study, therefore, assessed sensitivity and specificity of plasma as a diagnostic in comparison with a combination of oral and nasal swab samples, and the implications for blood transfusion. Oropharyngeal (OP) and nasopharyngeal (NP) swab samples were obtained from 125 individuals suspected to have COVID-19 and stored in viral transport medium (VTM) tubes. Ten millilitres of blood samples in EDTA were also obtained by venepuncture and spun to obtain plasma. Viral RNA was obtained from both swabs and plasma by manual extraction with Qiagen QIAamp viral RNA Mini Kit. Detection was done using a real time fluorescent RT-qPCR BGI kit, on a QuantStudio 3 real-time PCR instrument. Average age of study participants was 41 years, with 74 (59.2%) being male. Out of the 125 individuals tested for COVID-19, 75 (60%) were positive by OP/NP swab. However, only 6 (4.8%) had a positive plasma result for COVID-19 with median Ct value of 32.4. Sensitivity and specificity of RT-PCR SARS-CoV-2 test using plasma was 8% and 100% respectively. There was no false positive recorded, but 69 (55.2%) false negatives were obtained by plasma. SARS-CoV-2 viral RNA was detected, albeit low (4.8%) in plasma. Plasma is likely not a suitable biological sample to diagnose acute SARS-CoV-2 infection. The implication of transfusing blood in this era of COVID-19 needs further investigations.
first_indexed 2024-04-11T20:54:05Z
format Article
id doaj.art-c049fc12d14d4133a81023fc6d8e4dbd
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T20:54:05Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c049fc12d14d4133a81023fc6d8e4dbd2022-12-22T04:03:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01166Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusionAzuka Patrick OkwuraiweChika Kingsley OnwuamahJoseph Ojonugwa ShaibuSamuel Olufemi AmooFehintola Anthonia IgeAyorinde Babatunde JamesLeona Chika OkoliAbul-Rahman AhmedJamda PonmakJudith O. SokeiSulaimon AkanmuBabatunde Lawal SalakoRosemary Ajuma AuduThe present global pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has lingered for over a year in its devastating effects. Diagnosis of coronavirus disease 2019 (COVID-19) is currently established with a polymerase chain reaction (PCR) test by means of oropharyngeal-, nasopharyngeal-, anal-swabs, sputum and blood plasma. However, oral and nasal swabs are more commonly used. This study, therefore, assessed sensitivity and specificity of plasma as a diagnostic in comparison with a combination of oral and nasal swab samples, and the implications for blood transfusion. Oropharyngeal (OP) and nasopharyngeal (NP) swab samples were obtained from 125 individuals suspected to have COVID-19 and stored in viral transport medium (VTM) tubes. Ten millilitres of blood samples in EDTA were also obtained by venepuncture and spun to obtain plasma. Viral RNA was obtained from both swabs and plasma by manual extraction with Qiagen QIAamp viral RNA Mini Kit. Detection was done using a real time fluorescent RT-qPCR BGI kit, on a QuantStudio 3 real-time PCR instrument. Average age of study participants was 41 years, with 74 (59.2%) being male. Out of the 125 individuals tested for COVID-19, 75 (60%) were positive by OP/NP swab. However, only 6 (4.8%) had a positive plasma result for COVID-19 with median Ct value of 32.4. Sensitivity and specificity of RT-PCR SARS-CoV-2 test using plasma was 8% and 100% respectively. There was no false positive recorded, but 69 (55.2%) false negatives were obtained by plasma. SARS-CoV-2 viral RNA was detected, albeit low (4.8%) in plasma. Plasma is likely not a suitable biological sample to diagnose acute SARS-CoV-2 infection. The implication of transfusing blood in this era of COVID-19 needs further investigations.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191972/?tool=EBI
spellingShingle Azuka Patrick Okwuraiwe
Chika Kingsley Onwuamah
Joseph Ojonugwa Shaibu
Samuel Olufemi Amoo
Fehintola Anthonia Ige
Ayorinde Babatunde James
Leona Chika Okoli
Abul-Rahman Ahmed
Jamda Ponmak
Judith O. Sokei
Sulaimon Akanmu
Babatunde Lawal Salako
Rosemary Ajuma Audu
Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
PLoS ONE
title Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
title_full Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
title_fullStr Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
title_full_unstemmed Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
title_short Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
title_sort low level sars cov 2 rna detected in plasma samples from a cohort of nigerians implications for blood transfusion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191972/?tool=EBI
work_keys_str_mv AT azukapatrickokwuraiwe lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT chikakingsleyonwuamah lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT josephojonugwashaibu lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT samuelolufemiamoo lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT fehintolaanthoniaige lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT ayorindebabatundejames lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT leonachikaokoli lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT abulrahmanahmed lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT jamdaponmak lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT judithosokei lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT sulaimonakanmu lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT babatundelawalsalako lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion
AT rosemaryajumaaudu lowlevelsarscov2rnadetectedinplasmasamplesfromacohortofnigeriansimplicationsforbloodtransfusion